Search results
John Bell (physician) Sir John Irving Bell GBE CH FRS FMedSci HonFREng [1] (born 1 July 1952 [2]) is a Canadian-British immunologist and geneticist. [3] From 2006 to 2011, he was President of the United Kingdom's Academy of Medical Sciences, and since 2002 he has held the Regius Chair of Medicine at the University of Oxford. [4]
- Canadian, British
- John Irving Bell, 1 July 1952 (age 71), Edmonton, Alberta, Canada
Feb 21, 2024 · Professor Sir John Bell’s connection with Oxford stretches back 50 years, when he arrived from Canada as a Rhodes Scholar at Magdalen College. Since then, Sir John has made significant contributions to both the University and the UK’s life sciences endeavours, and his ground breaking research has contributed significantly to our ...
May 7, 2022 · Sir John Bell. Bell chairs Immunocore, whose treatments use the body’s immune system to kill cancer. Its drugs are developed in Oxford, but it is listed on America’s Nasdaq exchange, where ...
Learn about the life and achievements of Professor Sir John Bell, the former President of The Academy of Medical Sciences and a leading immunologist at Oxford University. He is Regius Professor of Medicine, a Fellow of the Royal Society, a Knight Bachelor and a member of various advisory boards and boards of directors.
Feb 24, 2021 · John Bell, a key figure in UK's covid-19 response and vaccine development, has not disclosed his financial interests with industry. The BMJ reveals how the government and Oxford University have refused to release his forms and emails.
- Paul D Thacker
- 2021
May 26, 2022 · Sir John Bell is Regius Professor of Medicine at the University of Oxford. He was the president of Britain’s Academy of Medical Sciences in 2006-11 and chair of the Office for Strategic ...
People also ask
Who is Mr John Bell?
Who was Sir Robert Bell?
Why did Oxford refuse to disclose Bell's financial interests?
John Bell is a professor of medicine at Oxford and a leading researcher in autoimmune disease and genetics. He is also a board member of several health and biotech organisations, and a former president of the Academy of Medical Sciences.
